Attached files
| file | filename |
|---|---|
| EXCEL - IDEA: XBRL DOCUMENT - PROVECTUS BIOPHARMACEUTICALS, INC. | Financial_Report.xls |
| EX-3.2 - EX-3.2 - PROVECTUS BIOPHARMACEUTICALS, INC. | d862762dex32.htm |
| EX-31.2 - EX-31.2 - PROVECTUS BIOPHARMACEUTICALS, INC. | d862762dex312.htm |
| EX-31.1 - EX-31.1 - PROVECTUS BIOPHARMACEUTICALS, INC. | d862762dex311.htm |
| 10-K - 10-K - PROVECTUS BIOPHARMACEUTICALS, INC. | d862762d10k.htm |
| EX-32 - EX-32 - PROVECTUS BIOPHARMACEUTICALS, INC. | d862762dex321.htm |
Exhibit 23
Consent of Independent Registered Public Accounting Firm
Provectus Biopharmaceuticals, Inc.
Knoxville, Tennessee
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (No. 333-182476) of Provectus Biopharmaceuticals, Inc. of our reports dated March 12, 2015 relating to the consolidated financial statements, and the effectiveness of Provectus Biopharmaceuticals, Inc.’s internal control over financial reporting, which appear in this Form 10-K.
/s/ BDO USA, LLP
Chicago, Illinois
March 12, 2015